Posts Tagged 'Johnson & Johnson'

Jury Finds for Johnson & Johnson in Pinnacle Hip Implant Case

In a blow to plaintiffs in the Pinnacle hip litigation, Johnson & Johnson has successfully defended the first trial over its Pinnacle hip implant. Bloomberg recently reported on the defense verdict in the first Pinnacle hip trial.

More than six thousand lawsuits have been filed over the Pinnacle device. Cases filed in federal court have been consolidated in Dallas. Plaintiffs in the Pinnacle hip implant litigation, as well as those filing lawsuits over other ...

continue reading...

FDA Addresses Cancer Risk of Morcellation Devices

A panel of Food and Drug Administration experts says that it is unlikely that power morcellation can be used to remove fibroids from women without the risk of spreading undetected cancers to other parts of the body. The FDA takes into consideration the opinions of its health advisors on these panels when making regulatory decisions about medical devices.

Power morcellators are used in the removal of fibroids and in some hysterectomies. Fibroids can cause ...

continue reading...

Johnson & Johnson Asks Doctors to Return Its Ethicon Power Morcellator Devices

Johnson and Johnson requests voluntary recall of Ethicon power morcellatorsThe FDA previously advised doctors to stop all use of power morcellators while the devices’ propensity to spread cancer was reviewed. Now J&J is pursuing a global, voluntary return of its power morcellator devices. An article in Reuters reports that this move comes as a result of concerns that the surgical device potentially spreads cancerous uterine growths in women.

Uterine growths, called fibroids, ...

continue reading...

Johnson & Johnson Alerted to Morcellator Cancer Risk in 2006

report indicates Johnson and Johnson knew of morcellator risk in 2006A report published in the Pittsburgh Business Times indicates that the Johnson & Johnson subsidiary responsible for manufacturing power morcellators was warned eight years ago that their device could increase the risk of spreading cancer. The news is based on a series of communications between the company and a Pennsylvania pathologist, Dr. Robert Lamparter, who requested that Johnson & Johnson reconsider the ...

continue reading...

Laparoscopic Uterine Power Morcellation Linked to Increased Cancer Risk

A Pennsylvania man is suing the manufacturer of a device used to remove large masses of tissue during minimally invasive surgeries. The man is alleging that the device caused the spread of cancerous tissue during his wife’s hysterectomy, ultimately resulting in her death. The device at issue is known as a morcellator, which operates by breaking up tissue into smaller fragments, allowing a surgeon to remove the tissue through a smaller incision than would be required in standard laparoscopic surgery.

On ...

continue reading...

$2.5 billion J&J hip settlement announced

Johnson & Johnson recently announced a $2.47 billion hip settlement through its DePuy subsidiary.

DePuy’s Articular Surface Replacement (ASR) hip implant was recalled in 2010. Now, an estimated 8,000 lawsuits are being filed over the device. The $2.47 billion settlement announced by J&J is likely to settle a large portion–though not all–of the pending cases.

The problematic all-metal hip implants promised more durability over the previous metal and plastic hip joints. Over the past ten years, they became popular among orthopedic surgeons. Now, patients are ...

continue reading...
Page 15 of 24 «...101314151617...»